Long-term risk of hip or forearm fractures in older occasional users of benzodiazepines.


Journal

British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323

Informations de publication

Date de publication:
11 2020
Historique:
received: 01 08 2019
revised: 21 03 2020
accepted: 24 03 2020
pubmed: 15 4 2020
medline: 29 7 2021
entrez: 15 4 2020
Statut: ppublish

Résumé

This article sought to study the association between patterns of benzodiazepine (BZD) use and the risk of hip and forearm fractures in people aged 50 and 75 years or more. In a representative cohort of the French National Health Insurance Fund of individuals aged 50 years or older (n = 106 437), we followed up BZD dispensing (reflecting their patterns of use) and the most frequent fall-related fractures (hip and forearm) for 8 years. We used joint latent class models to simultaneously identify BZD dispensing trajectories and the risk of fractures in the entire cohort and in those 75 years or older). We used a survival model to estimate the adjusted hazard ratios (aHRs) between these trajectories and the risk of fractures. In the entire cohort, we identified 5 BZD trajectories: non-users (76.7% of the cohort); occasional users (15.2%); decreasing users (2.6%); late increasing users (3.0%); and early increasing users (2.4%). Compared with non-users, fracture risk was not increased in either occasional users (aHR = 0.99, 95% confidence interval [CI] 0.99-1.00) or in decreasing users (aHR = 0.90, 95% CI 0.74-1.08). It was significantly higher in early increasing users (aHR = 1.86, 95% CI 1.62-2.14) and in late increasing users (aHR = 1.39, 95% CI 1.15-1.60). We observed similar trajectories and risk levels in the people older than 75 years. Occasional BZD use, which is compatible with current recommendations, was not associated with an excess risk of the most frequent fall-related fractures in people older than 50 or 75 years.

Identifiants

pubmed: 32285959
doi: 10.1111/bcp.14307
pmc: PMC7576621
doi:

Substances chimiques

Benzodiazepines 12794-10-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2155-2164

Subventions

Organisme : French National Agency for Medicines and Health Products Safety
ID : 2014S029

Informations de copyright

© 2020 The British Pharmacological Society.

Références

Br J Clin Pharmacol. 2017 Jul;83(7):1397-1404
pubmed: 28268245
J Aging Health. 2011 Mar;23(2):329-46
pubmed: 20947876
Acta Psychiatr Scand. 2018 Apr;137(4):328-341
pubmed: 29441519
Pharmacopsychiatry. 2011 May;44(3):96-101
pubmed: 21328195
Drugs Aging. 2012 May 1;29(5):359-76
pubmed: 22550966
Rev Epidemiol Sante Publique. 2010 Aug;58(4):286-90
pubmed: 20598822
Br J Clin Pharmacol. 2020 Nov;86(11):2155-2164
pubmed: 32285959
Epidemiol Psychiatr Sci. 2016 Jun;25(3):214-6
pubmed: 26818890
Br J Clin Pharmacol. 2015 Oct;80(4):796-807
pubmed: 25619317
JAMA Intern Med. 2013 May 13;173(9):754-61
pubmed: 23460413
Maturitas. 2017 Jul;101:17-22
pubmed: 28539164
Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):402-411
pubmed: 27910177
Eur Psychiatry. 2015 Nov;30(8):1037-47
pubmed: 26545257
Soc Sci Med. 2006 Mar;62(5):1237-49
pubmed: 16143440
J Am Geriatr Soc. 2003 Mar;51(3):364-70
pubmed: 12588580
Injury. 2006 Aug;37(8):691-7
pubmed: 16814787
Br J Clin Pharmacol. 2008 Aug;66(2):276-82
pubmed: 18460035
Br J Clin Pharmacol. 2014 Feb;77(2):295-301
pubmed: 22882333
J Am Geriatr Soc. 1999 Jan;47(1):30-9
pubmed: 9920227
Br J Clin Pharmacol. 2016 Apr;81(4):759-67
pubmed: 26613560
Eur J Clin Pharmacol. 2017 Aug;73(8):927-935
pubmed: 28456823
Sleep. 2017 Nov 1;40(11):
pubmed: 28958019
J Clin Epidemiol. 2005 Apr;58(4):323-37
pubmed: 15862718
BMC Musculoskelet Disord. 2011 May 20;12:105
pubmed: 21599967
Ann Intern Med. 2010 Mar 16;152(6):380-90
pubmed: 20231569
Br J Clin Pharmacol. 2014 Oct;78(4):738-47
pubmed: 24661192
Drugs Aging. 2008;25(1):61-70
pubmed: 18184030
Pharmacoepidemiol Drug Saf. 2005 Jul;14(7):455-63
pubmed: 15651088
Am Fam Physician. 2000 Apr 1;61(7):2159-68, 2173-4
pubmed: 10779256
JAMA. 2018 Apr 24;319(16):1705-1716
pubmed: 29710140
J Gerontol A Biol Sci Med Sci. 2007 Oct;62(10):1172-81
pubmed: 17921433
Arch Intern Med. 2011 Nov 14;171(20):1831-7
pubmed: 21949033
Arch Intern Med. 2009 Nov 23;169(21):1952-60
pubmed: 19933955

Auteurs

Hélène Carrier (H)

Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
IHU-Méditerranée Infection, Marseille, France.
Department of General Practice, Aix-Marseille University, Marseille, France.
ORS Paca, Regional Health Observatory, Provence-Alpes-Côte d'Azur, Marseille, France.

Sébastien Cortaredona (S)

Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
IHU-Méditerranée Infection, Marseille, France.

Viviane Philipps (V)

Univ. Bordeaux, Inserm, Bordeaux Population Health, UMR 1219, ISPED, Bordeaux, France.

Hélène Jacqmin-Gadda (H)

Univ. Bordeaux, Inserm, Bordeaux Population Health, UMR 1219, ISPED, Bordeaux, France.

Marie Tournier (M)

Univ. Bordeaux, Inserm, Bordeaux Population Health, UMR 1219, ISPED, Bordeaux, France.
Centre Hospitalier Charles Perrens, Bordeaux, France.

Hélène Verdoux (H)

Univ. Bordeaux, Inserm, Bordeaux Population Health, UMR 1219, ISPED, Bordeaux, France.
Centre Hospitalier Charles Perrens, Bordeaux, France.

Pierre Verger (P)

Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
IHU-Méditerranée Infection, Marseille, France.
ORS Paca, Regional Health Observatory, Provence-Alpes-Côte d'Azur, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH